About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Pax7tm1(cre/ERT2)Gaka
targeted mutation 1, Gabrielle Kardon
MGI:5141477
Summary 9 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Pax7tm1(cre/ERT2)Gaka/Pax7+
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6 MGI:5141594
cn2
2310065F04Riktm1.1Boet/2310065F04Riktm1.1Boet
Ino80tm1.1Jland/Ino80tm1.1Jland
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl MGI:7645256
cn3
Prmt7tm1.1Rchd/Prmt7tm1.1Rchd
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6NCrl MGI:6314346
cn4
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
Pax7tm1(cre/ERT2)Gaka/Pax7tm1(cre/ERT2)Gaka
Paxbp1tm1.1Nju/Paxbp1tm1.1Nju
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCr MGI:6827448
cn5
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S6/SvEvTac * C57BL/6 MGI:5495319
cn6
Six1tm2.1Mair/Six1tm2.1Mair
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6Cr * C57BL/6NTac MGI:5449865
cn7
Zfp422em1Mode/Zfp422em1Mode
Pax7tm1(cre/ERT2)Gaka/Pax7+
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl MGI:6477293
cn8
Pax7tm1(cre/ERT2)Gaka/0
Snhg15tm1.1Nju/Snhg15tm1.1Nju
involves: C57BL/6J * SJL/J MGI:6478905
cx9
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/?
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl MGI:6120566


Genotype
MGI:5141594
cn1
Allelic
Composition
Pax7tm1(cre/ERT2)Gaka/Pax7+
Gt(ROSA)26Sortm1(DTA)Mrc/Gt(ROSA)26Sor+
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(DTA)Mrc mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• 83-84% of satellite cells are ablated in the right tibialis anterior muscle after 5 doses of tamoxifen and 5days after muscle damage induced by BaCl2 injection
• reduced fibroblast expansion by 52% 5 days after muscle injury in tamoxifen treated mice
• 89% reduction in regenerating myofibers 5 days after muscle injury in tamoxifen treated mice
• muscle regeneration dramatically impaired 28 days after injury
• right tibialis anterior muscle entirely fibrotic at 28 days and uninjured left tibialis anterior is reduced by 38%
• similar result when damage induced with cardiotoxin, no recovery after 56 days




Genotype
MGI:7645256
cn2
Allelic
Composition
2310065F04Riktm1.1Boet/2310065F04Riktm1.1Boet
Ino80tm1.1Jland/Ino80tm1.1Jland
Pax7tm1(cre/ERT2)Gaka/Pax7+
Genetic
Background
involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCrl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
2310065F04Riktm1.1Boet mutation (0 available); any 2310065F04Rik mutation (0 available)
Ino80tm1.1Jland mutation (1 available); any Ino80 mutation (440 available)
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
N
• adult mice treated with tamoxifen show complete abrogation of the increased number of Pax7+ muscle stem cells (satellite cells) seen in homozygous 2310065F04Riktm1.1Boet mice




Genotype
MGI:6314346
cn3
Allelic
Composition
Prmt7tm1.1Rchd/Prmt7tm1.1Rchd
Pax7tm1(cre/ERT2)Gaka/Pax7+
Genetic
Background
involves: 129S4/SvJaeSor * 129S6/SvEvTac * C57BL/6NCrl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
Prmt7tm1.1Rchd mutation (0 available); any Prmt7 mutation (41 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• satellite cells isolated from 8 month tamoxifen-treated mice exhibit premature senescence unlike control cells
• tamoxifen-treated mice subjected to cardiotoxin-induced muscle injury exhibit smaller and poorly organized regenerating myofibers compared with control mice

cellular
• satellite cells or cardiotoxin-injured tibialis anterior muscles isolated from 8 month tamoxifen-treated mice exhibit premature senescence unlike control cells

homeostasis/metabolism
• cardiotoxin-injured tibialis anterior muscles isolated from 8 month tamoxifen-treated mice exhibit premature senescence unlike control cells




Genotype
MGI:6827448
cn4
Allelic
Composition
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sortm1(EYFP)Cos
Pax7tm1(cre/ERT2)Gaka/Pax7tm1(cre/ERT2)Gaka
Paxbp1tm1.1Nju/Paxbp1tm1.1Nju
Genetic
Background
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6NCr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(EYFP)Cos mutation (11 available); any Gt(ROSA)26Sor mutation (993 available)
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
Paxbp1tm1.1Nju mutation (0 available); any Paxbp1 mutation (46 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• fragmented mitochondria, largely restricted to perinuclear region, lacking interconnecting tubular network in activated muscle stem cells
• defective cellular respiration and glycolysis
• defective cellular respiration and glycolysis
• defective mitochondrial biogenesis in activated muscle stem cells
• defective cellular respiration and glycolysis

muscle
• virtual absence of regenerating myofibers 5 days after injection of cardiotoxin (CTX) into the tibialis anterior (TA) muscles and no muscle regeneration after 14 nor 30 days
• adipocyte infiltration 30 days after injection of cardiotoxin (CTX) into the tibialis anterior (TA) muscles




Genotype
MGI:5495319
cn5
Allelic
Composition
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/Pax7+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm4(EWSR1/ATF1)Mrc mutation (0 available); any Gt(ROSA)26Sor mutation (993 available)
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• when tamoxifen is administered after 3 weeks of age myopathy develops by 12 months

neoplasm
N
• no abnormal tumor development when treated with tamoxifen after 3 weeks of age




Genotype
MGI:5449865
cn6
Allelic
Composition
Six1tm2.1Mair/Six1tm2.1Mair
Pax7tm1(cre/ERT2)Gaka/Pax7+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6Cr * C57BL/6NTac
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
Six1tm2.1Mair mutation (0 available); any Six1 mutation (19 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Perturbed myogenic differentiation of Six1tm2.1Mair/Six1tm2.1Mair Pax7tm1(cre/ERT2)Gaka/Pax7+ satellite cell descendants ex vivo

muscle
N
• normal muscle tissue weights or histology up to a year after tamoxifen treatment
• in tamoxifen-treated mice subjected to a single cardiotoxin injury
• satellite cells from tamoxifen-treated mice exhibit reduced ability to differentiate of satellite cell descendants ex vivo and increased self-renewal capacity in vivo compared with control cells
• ex vivo satellite cells from tamoxifen-treated mice exhibit increased self-renewal compared with control cells
• however, satellite cells exhibit normal quiescence, activation and proliferation and polarity of division
• satellite cells from tamoxifen-treated mice form smaller myotubes containing fewer nuclei ex vivo compared with control cells
• regenerating muscle from tamoxifen-treated mice subjected to a single cardiotoxin injury exhibit smaller newly formed myofibers with fewer nuclei, numerous lagged fibers of small caliber, reduced cell size and necrotic myofibers compared with controls




Genotype
MGI:6477293
cn7
Allelic
Composition
Zfp422em1Mode/Zfp422em1Mode
Pax7tm1(cre/ERT2)Gaka/Pax7+
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6J * C57BL/6NCrl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
Zfp422em1Mode mutation (0 available); any Zfp422 mutation (16 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• decrease in the number of myogenin positive cells in cultured satellite cells from tamoxifen treated mice indicating a defect in myoblast differentiation
• when induced to differentiate for 3 days satellite cells for fewer myotubes and have reduced fusion and differentiation indices
• following CTX-induced muscle injury muscles in tamoxifen treated mice show smaller regenerated myofiber cross-section area

cellular
• decrease in the number of myogenin positive cells in cultured satellite cells from tamoxifen treated mice indicating a defect in myoblast differentiation
• when induced to differentiate for 3 days satellite cells for fewer myotubes and have reduced fusion and differentiation indices




Genotype
MGI:6478905
cn8
Allelic
Composition
Pax7tm1(cre/ERT2)Gaka/0
Snhg15tm1.1Nju/Snhg15tm1.1Nju
Genetic
Background
involves: C57BL/6J * SJL/J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
Snhg15tm1.1Nju mutation (0 available); any Snhg15 mutation (9 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
muscle
• delayed muscle regeneration after knockout induction by tamoxifen injection and BaCl2 injection into tibialis anterior (TA) muscles at age 2 months: reduced number of embryonic myosin heavy chain expressing myofibers 4 days after BaCl2 injection
• reduced myoblast proliferation after BaCl2 injection
• reduced in vitro proliferation of stem cells after BaCl2 injection




Genotype
MGI:6120566
cx9
Allelic
Composition
Gt(ROSA)26Sortm1.1(DUX4*)Plj/Gt(ROSA)26Sor+
Pax7tm1(cre/ERT2)Gaka/?
Genetic
Background
involves: 129S6/SvEvTac * C57BL/6 * C57BL/6NCrl
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1.1(DUX4*)Plj mutation (1 available); any Gt(ROSA)26Sor mutation (993 available)
Pax7tm1(cre/ERT2)Gaka mutation (1 available); any Pax7 mutation (38 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are viable and healthy in the absence of tamoxifen





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
11/12/2024
MGI 6.24
The Jackson Laboratory